QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Healthpeak Properties, Inc. (DOC)

Real Estate

No action
Fundamental
4
Sentiment
3
Technical
2

Do Nothing: technicalScore 2 (below the required 3) on a weak-bearish chart — price below SMA20/SMA50/EMA21 with MACD negative, RSI 40 and an 09-18 distribution day on 2.4x volume; no pullback limit qualifies (countertrend: price < SMA50 with MACD < 0, and RSI is not oversold) and no breakout stop qualifies (no momentum confirmation; nearest settled anchor 20.74 would enter into SMA20/SMA50 overhead, so its 1.47 R/R is academic).

Analysis as of 2026-09-18· more than 2 trading days ago

Company overview

Healthpeak Properties, Inc. is a real estate investment trust (REIT) focused on acquiring, managing, and developing properties for medical research and healthcare services. It is part of the S&P 500 index.

Fundamental

good
Fundamental4
Solid fundamentals

Healthpeak shows stable liquidity and reasonable valuation metrics, but interest coverage remains a key concern.

Healthpeak’s latest SEC filings show solid liquidity and no explicit going‑concern language, while interim 2026 results and guidance point to stabilization after a volatile GAAP 2025. Leverage is moderate for a healthcare equity REIT (net debt/EBITDA ~4.9x), enterprise multiples look reasonable (EV/EBITDA ~12.9x), and the monthly dividend is established—but interest coverage (~1.5x) keeps rate sensitivity as the main watch item.

Sentiment

fair
Sentiment3
Mixed sentiment

Sentiment is flat-to-mildly-positive with a $500M buyback but insider-selling concerns.

Q2 2026 results (2026-08-04, announced) with raised FY26 guidance and a $500M buyback authorization anchor a mixed, partially priced setup; media sentiment delta is flat (baseline ≈ +0.14 → current ≈ +0.10), retail velocity is indeterminate, and a moderate red-flag cap applies for conflicting catalyst signals (reception-positive buyback vs rumored insider selling).

Technical

weak
Technical2
Weak bearish trend

The stock is in a weak bearish trend with no confirmed bullish setup.

DOC closed at 20.33 on 09-18, below its SMA20 (20.80), SMA50 (21.30), EMA9 (20.44), EMA21 (20.68) and daily VWAP (20.44). MACD is negative (line -0.25 under signal -0.23, histogram -0.02), RSI is 40.3 and ADX is 19.9 — a weak, low-trend-strength drift down from the late-July 22.95 peak, cushioned only by the 20.0-20.1 support shelf and the rising SMA200 (18.72). The 09-18 session printed a distribution-style down day on 2.4x average volume. No tradable bullish setup: a pullback/oversold limit is countertrend (price < SMA50 with MACD < 0) and RSI is not genuinely oversold; a breakout/momentum stop has no momentum confirmation with SMA20/SMA50 overhead. Technical score 2; Do Nothing.

You’re looking at 2026-09-18 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.